Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

75.35
-1.9700-2.55%
Post-market: 75.350.00000.00%19:39 EDT
Volume:379.16K
Turnover:28.69M
Market Cap:1.73B
PE:16.60
High:77.81
Open:77.33
Low:74.81
Close:77.32
52wk High:99.50
52wk Low:70.15
Shares:22.97M
Float Shares:20.28M
Volume Ratio:1.41
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.90
PE(LYR):22.70

Loading ...

ANI Pharma General Counsel Meredith Cook Sells 500 Shares for $37,740

Reuters
·
Aug 14

ANI Pharma SVP, Generics Ori Gutwerg Reports Sale of 3,162 Common Shares Worth $243,474

Reuters
·
Aug 12

These Analysts Slash Their Forecasts On ANI Pharmaceuticals After Q2 Results

Benzinga Earnings
·
Aug 10

ANI Pharmaceuticals is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Aug 10

J.P. Morgan Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
Aug 10

ANI Pharmaceuticals price target lowered to $119 from $124 at Guggenheim

TIPRANKS
·
Aug 10

Tonix Q2 Revenue Rises Sharply on Tonmya Launch

Reuters
·
Aug 10

Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth

Reuters
·
Aug 10

Veru Q3 Net Loss Narrows on Lower G&A Expenses

Reuters
·
Aug 10

U.S. Research Roundup-Compass Minerals, Duke Energy, Tesla

Reuters
·
Aug 10

ANI Pharmaceuticals Inc : Canaccord Genuity Cuts Target Price to $90 from $91

THOMSON REUTERS
·
Aug 10

ANI Pharmaceuticals (ANIP) Stock Slides As Cortrophin Concentration Clouds Profit Quality

Simply Wall St.
·
Aug 09

Sector Update: Healthcare Stocks Rise Late Afternoon

MT Newswires Live
·
Aug 08

ANI Pharmaceuticals Slides After Lowering FY26 Guidance for Cortrophin Gel Revenue

Dow Jones
·
Aug 07

ANI Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

ANI Pharma Cuts Full-Year Revenue Forecast for Key Drug; Shares Fall

Reuters
·
Aug 07

ANI Pharma Investor Presentation Spotlights Rare Disease Shift, Targets 2026 Net Revenue of $1.1 Billion

Reuters
·
Aug 07

ANI Pharmaceuticals Shares Down 8.1% Premarket After Co Forecasts 2026 Revenue Below Estimates

THOMSON REUTERS
·
Aug 07

GUIDANCE: (ANIP) ANI Pharmaceuticals Expects 2026 Adjusted EPS Range $9.19 - $9.69, vs. FactSet Est of $9.45

MT Newswires Live
·
Aug 07

ANI Pharma Q2 FY26 GAAP Net Income Climbs 203.5% to $24.7 Million; Net Revenues Rise 25.9% to $266 Million

Reuters
·
Aug 07